Akay, O. M. I. Et Al. 2014. BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients. CANCER GENETICS , vol.207 , 87-93.

Akay, O. M. I., Durak Aras, B., Işıksoy, S., Toprak, C., Mutlu, F., Artan, S., ... Oner, U.(2014). BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients. CANCER GENETICS , vol.207, 87-93.

Akay, Olga Et Al. "BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients," CANCER GENETICS , vol.207, 87-93, 2014

Akay, Olga M. Et Al. "BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients." CANCER GENETICS , vol.207, pp.87-93, 2014

Akay, O. M. I. Et Al. (2014) . "BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients." CANCER GENETICS , vol.207, pp.87-93.

@article{article, author={Olga Me Item Akay Et Al. }, title={BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients}, journal={CANCER GENETICS}, year=2014, pages={87-93} }